Trial Details
COMPLETEDBasic Information
| Clinical ID | c1240 |
|---|---|
| Identifier | NCT00063830 |
| Trial Title | ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Alicaforsen |
Participant Information
| Sponsor | Ionis Pharmaceuticals, Inc. |
|---|---|
| City | Sacramento |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2003-04-03 |
|---|---|
| Primary Completion Date | 2004-10-11 |
| Completion Date | 2004-10-11 |